<?xml version='1.0' encoding='utf-8'?>
<document id="29601930"><sentence text="Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions." /><sentence text="Peritoneal dialysis (PD) performed with transmembrane pH-gradient liposomes was reported to efficiently remove ammonia from the body, representing a promising alternative to current standard-of-care for patients with severe hepatic encephalopathy"><entity charOffset="111-118" id="DDI-PubMed.29601930.s2.e0" text="ammonia" /></sentence><sentence text=" In this study, we further characterized the properties of liposome-supported peritoneal dialysis (LSPD) by 1) assessing its in-use stability in the presence of ascitic fluids from liver-disease patients; 2) investigating its interactions with drugs that are commonly administered to acute-on-chronic liver failure patients; and 3) analyzing the in vivo extraction profile of LSPD" /><sentence text=" We found that LSPD fluid maintained its in vitro ammonia uptake capability when combined with ascitic fluids" /><sentence text=" The co-incubation of selected drugs (e" /><sentence text="g" /><sentence text=", beta-blockers, antibiotics, diuretics) with LSPD fluids and ammonia resulted in limited interaction effects for most compounds except for two fluoroquinolones and propranolol"><entity charOffset="62-69" id="DDI-PubMed.29601930.s7.e0" text="ammonia" /><entity charOffset="144-160" id="DDI-PubMed.29601930.s7.e1" text="fluoroquinolones" /><entity charOffset="165-176" id="DDI-PubMed.29601930.s7.e2" text="propranolol" /><pair ddi="false" e1="DDI-PubMed.29601930.s7.e0" e2="DDI-PubMed.29601930.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29601930.s7.e0" e2="DDI-PubMed.29601930.s7.e1" /><pair ddi="false" e1="DDI-PubMed.29601930.s7.e0" e2="DDI-PubMed.29601930.s7.e2" /><pair ddi="false" e1="DDI-PubMed.29601930.s7.e1" e2="DDI-PubMed.29601930.s7.e1" /><pair ddi="false" e1="DDI-PubMed.29601930.s7.e1" e2="DDI-PubMed.29601930.s7.e2" /></sentence><sentence text=" However, considering the experimental set-up, these results should be interpreted with caution and confirmatory drug-drug interaction studies in a clinical setting will be required" /><sentence text=" Finally, metabolite-mapping analysis on dialysates of LSPD-treated rats revealed that the liposomes did not remove important metabolites more than a conventional PD fluid" /><sentence text=" Overall, these findings confirm that LSPD is a potentially safe and effective approach for treating hyperammonemic crises in the context of acute-on-chronic liver failure" /><sentence text="" /></document>